At this time, posts about Hanmi Pharm are rapidly increasing on portals and stock communities. Today, institutional investors have net purchased 1,000 shares. Hanmi Pharm is known as a pharmaceutical company specializing in the production of prescription drugs.

As of 12:30 PM on the 5th, Hanmi Pharm's stock price rose 29.91% from the previous day to 360,500 KRW, with a trading volume of 508,208 shares, which is 191.89% of the average trading volume over the past 5 days. On July 28, Hanmi Pharm became a market issue with the news of "Strong performance due to global clinical effects of new drugs."

In addition to Hanmi Pharm, posts by investors are also surging for Data Solution (263800), Dream Security (203650), and Samsung SDI (006400).

※Source: AI Investment Assistant AI Rassi

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.




This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing